Global Health Multistakeholder Dialogue Recommendations to the G7 2024
The culmination of an independent, nonstate actor-led Global Health Multistakeholder Dialogue, this report reviews the progress of the G7’s past commitments to global health issues including antimicrobial resistance and pandemic prevention, preparedness and response;
identifies remaining challenges to be addressed by the G7; and seeks to promote coordination and consensus on global health priorities among nonstate stakeholders while transitioning between the 2023 Japanese G7 and the 2024 Italian G7 presidencies.
Japan’s Foreign Policy and Global Health Diet Roundtable Series
JCIE launched the “Global Health Diet Roundtable” series in 2018, followed by the “Japan’s Foreign Policy and Global Health Diet Roundtable” series in December 2023, as part of its Global Health and Human Security Program. The aim of these two series is to bring together a bipartisan assortment of Japanese parliamentarians and deepen their understanding of global health issues so that they can play a leadership role in the global health field.
JCIE Publication | Strengthening Human Capital Development for Clinical Trials to Prepare for Future Health Crises
This report, available in both English and Japanese, outlines recommendations of the Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia the Task Force on ways to implement adequate measures, based on a comprehensive and consistent strategy, to develop the necessary research and research support personnel and to maintain and enhance academic research organization functions.
Positive Lives Asia—Photo Exhibitions
As one of its community projects to promote HIV/AIDS awareness and education, the Levi Strauss Foundation has been supporting the production of “Positive Lives Asia,” a series of photo-documentary essays featuring the stories of people affected by HIV and AIDS and positive responses to the epidemic. JCIE collaborated in the administration of the exhibit.
Regulatory Harmonization Task Force
In 2018, JCIE’s Executive Committee on Global Health and Human Security created a Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia. The group, comprised of 15 experts from industry, academia, and government, seeks to formulate recommendations on how Japan could improve access to pharmaceuticals and medical devices in Asia.
Healthy and Active Aging
A look at the critical impact of aging on Japanese and other societies. JCIE is promoting dialogue, exchange, and research to understand the implications of aging societies worldwide and to share best practices to ensure that Japan and others can enjoy healthy longevity.
Healthy and Active Aging in Asia
A look at the critical impact of aging on Japanese and other societies. Rapid population aging is one of the key challenges faced not only by Japan but by an increasing number of ASEAN and East Asian countries. JCIE’s new program on Healthy and Active Aging in Asia aims to contribute to the promotion of bilateral and regional cooperation on aging-related challenges in Asia.
US-Japan Healthy and Resilient Aging Program
The US-Japan Healthy & Resilient Aging program promotes US-Japan collaboration on aging issues. The program will facilitate robust dialogues at the community and national levels that engage a broad spectrum of stakeholders and spark future collaboration for the benefit of both countries and the Asia-Pacific region as a whole.
US-Japan Global Health Dialogue
JCIE gathers policy experts and senior officials from various US and Japanese government agencies for a series of high-level dialogues to identify areas where the two countries can deepen cooperation on global health. Meetings have been co-organized with the UN Foundation, the Center for Strategic and International Studies (CSIS), and the National Academy of Medicine (NAM).
Bilateral Policy Dialogues
In the 1980s and 1990s, JCIE/Japan launched a number of annual policy dialogues that brought together leaders from various sectors to discuss the key domestic, bilateral, and international issues of the day.